KLINIQ reported its first-half 2026 operating results, growing in line with targets. Revenue from sales and services totaled approximately 2,213 million baht, up 33% from the same period last year, with net profit of about 233 million baht, also up 33%. As a result, the company raised its full-year revenue target from 4,150 million baht to 4,500 million baht. Dr. Apirut Thongwat, Group CEO, revealed that growth was driven by core businesses, especially the Aesthetic and Wellness segment under a multi-brand strategy through brands such as THE KLINIQUE, L.A.B.X, L'CLINIC, and Acne Labs+. Meanwhile, the Plastic Surgery business showed improvement, with second-quarter 2026 revenue of 198.3 million baht and net profit of 9.2 million baht. The overall gross profit margin stood at 51.2%, up from 50.8% in the same period last year. Same-store sales growth from cash sales expanded 21.5%, reflecting the strength of existing branches. As of the end of the second quarter, the company operated a total of 84 branches, up from 77 in the previous year.
The Klinique Med Clinic PCLRevenue up 33% driven by core aesthetic and wellness segment growth, with same-store sales up 21.5%.
